Insider Trading & Ownership - Iwicki Mark T

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Iwicki Mark T
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-26
Sale
2024-06-27
8:00 pm
KALA BIO Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
15,168$4.75$72,048263,755
(Direct)
View
2024-05-31
Sale
2024-06-03
8:00 pm
KALA BIO Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
7,392$6.09$45,017278,923
(Direct)
View
2024-01-04
Sale
2024-01-05
4:04 pm
KALA BIO Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
4,539$6.73$30,547350,815
(Direct)
View
2023-01-04
Sale
2023-01-06
8:00 pm
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
198$28.54$5,65145,966
(Direct)
View
2022-10-26
Sale
2022-10-28
4:15 pm
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
561$6.52$3,6584,464
(Direct)
View
2022-06-27
Sale
2022-06-29
8:09 pm
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
7,975$0.37$2,951251,183
(Direct)
View
2022-01-04
Sale
2022-01-05
8:00 pm
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
9,518$1.3$12,3731,034,158
(Direct)
View
2021-10-26
Sale
2021-10-28
8:01 pm
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
27,598$1.8$49,676268,676
(Direct)
View
2021-06-28
Sale
2021-06-29
5:25 pm
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
7,586$5.77$43,771296,274
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-08
Option Award
2024-06-11
5:28 pm
N/A
2034-06-07
Akero Therapeutics Inc.AKROIwicki Mark T
Director
26,000$026,000
(Direct)
View
2024-06-06
Option Award
2024-06-10
4:24 pm
N/A
2034-06-05
Third Harmonic Bio Inc.THRDIwicki Mark T
Director
20,000$020,000
(Direct)
View
2024-06-05
Option Award
2024-06-07
6:00 pm
N/A
2034-06-04
Aerovate Therapeutics Inc.AVTEIwicki Mark T
Director
12,500$012,500
(Direct)
View
2024-05-07
Option Award
2024-05-09
4:30 pm
N/A
2034-05-07
Merus N.V.MRUSIwicki Mark T
Director
8,844$08,844
(Direct)
View
2024-03-25
Option Award
2024-03-27
5:40 pm
N/A
2034-03-24
Q32 Bio Inc.QTTBIwicki Mark T
Director
25,534$025,534
(Direct)
View

Ownership
2024-03-27
5:16 pm
N/A
2031-01-21
Q32 Bio Inc.QTTBIwicki Mark T
Director
0$044,837
(Direct)
View
2024-01-04
Option Award
2024-01-05
4:04 pm
N/A
2034-01-03
KALA BIO Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
78,800$0350,815
(Direct)
View
2023-06-23
Option Award
2023-06-27
5:39 pm
N/A
2033-06-22
Akero Therapeutics Inc.AKROIwicki Mark T
Director
15,000$015,000
(Direct)
View
2023-06-22
Option Award
2023-06-23
8:00 pm
N/A
2033-06-21
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
370,704$0488,385
(Direct)
View
2023-06-08
Option Award
2023-06-12
4:16 pm
N/A
2033-06-08
Merus N.V.MRUSIwicki Mark T
Director
14,414$014,414
(Direct)
View
2023-06-06
Option Award
2023-06-08
6:00 pm
N/A
2033-06-05
Aerovate Therapeutics Inc.AVTEIwicki Mark T
Director
12,500$012,500
(Direct)
View
2023-06-06
Option Award
2023-06-08
4:18 pm
N/A
2033-06-05
Third Harmonic Bio Inc.THRDIwicki Mark T
Director
16,250$016,250
(Direct)
View
2023-05-31
Disposition
2023-06-02
8:00 pm
N/A
2025-06-03
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
71,715$0117,681
(Direct)
View
2023-05-31
Option Award
2023-06-02
8:00 pm
N/A
N/A
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
71,715$0117,681
(Direct)
View
2023-04-14
Exercise
2023-04-17
08:26 am
N/A
N/A
Merus N.V.MRUSIwicki Mark T
Director
36,944$6.5773,576
(Direct)
View
2023-04-14
Exercise
2023-04-17
08:26 am
N/A
N/A
Merus N.V.MRUSIwicki Mark T
Director
36,632$7.9773,576
(Direct)
View
2023-04-14
Exercise
2023-04-17
08:26 am
N/A
2023-06-02
Merus N.V.MRUSIwicki Mark T
Director
73,576$073,576
(Direct)
View
2023-03-14
Option Award
2023-03-15
8:00 pm
N/A
2032-01-03
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
1,512$01,512
(Direct)
View
2023-03-06
Disposition
2023-03-08
5:02 pm
N/A
2032-02-16
Third Harmonic Bio Inc.THRDIwicki Mark T
Director
49,080$049,080
(Direct)
View
2023-03-06
Option Award
2023-03-08
5:02 pm
N/A
2032-02-16
Third Harmonic Bio Inc.THRDIwicki Mark T
Director
49,080$049,080
(Direct)
View
2023-01-04
Option Award
2023-01-06
8:00 pm
N/A
N/A
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
41,700$045,966
(Direct)
View
2022-10-26
Option Award
2022-10-27
4:55 pm
N/A
2032-10-25
Third Harmonic Bio Inc.THRDIwicki Mark T
Director
13,667$013,667
(Direct)
View

Ownership
2022-09-14
6:08 pm
N/A
N/A
Third Harmonic Bio Inc.THRDIwicki Mark T
Director
0$0168,343
(Direct)
View
2022-06-21
Option Award
2022-06-22
5:00 pm
N/A
2032-06-20
Aerovate Therapeutics Inc.AVTEIwicki Mark T
Director
12,500$012,500
(Direct)
View
2022-06-02
Option Award
2022-06-03
4:06 pm
N/A
2032-06-01
Akero Therapeutics Inc.AKROIwicki Mark T
Director
15,000$015,000
(Direct)
View
2022-05-31
Option Award
2022-06-02
4:05 pm
N/A
2032-05-31
Merus N.V.MRUSIwicki Mark T
Director
16,604$016,604
(Direct)
View
2022-01-03
Option Award
2022-01-05
8:00 pm
N/A
2032-01-03
Kala Pharmaceuticals Inc.KALAIwicki Mark T
CHIEF EXECUTIVE OFFICER
775,000$01,034,158
(Direct)
View
2021-04-02
Option Award
2021-07-01
6:33 pm
N/A
2031-04-01
Aerovate Therapeutics Inc.AVTEIwicki Mark T
Director
158,497$0158,497
(Direct)
View

Ownership
2021-06-29
7:41 pm
N/A
2031-04-01
Aerovate Therapeutics Inc.AVTEIwicki Mark T
Director
0$0116,297
(Direct)
View
2021-06-01
Option Award
2021-06-03
5:58 pm
N/A
2031-05-31
Akero Therapeutics Inc.AKROIwicki Mark T
Director
13,000$013,000
(Direct)
View
2021-05-28
Option Award
2021-06-02
4:10 pm
N/A
2031-05-28
Merus N.V.MRUSIwicki Mark T
Director
6,120$06,120
(Direct)
View
2021-01-28
Option Award
2021-02-01
9:45 pm
N/A
2031-01-28
Pulmatrix Inc.PULMIwicki Mark T
Director
15,000$015,000
(Direct)
View
2021-01-04
Option Award
2021-01-05
4:50 pm
N/A
2031-01-03
Kala Pharmaceuticals Inc.KALAIwicki Mark T
Chief Executive Officer
379,000$0606,860
(Direct)
View
2020-10-26
Option Award
2020-10-28
8:24 pm
N/A
N/A
Kala Pharmaceuticals Inc.KALAIwicki Mark T
Chief Executive Officer
178,300$0227,860
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
17,500$16.240
(Direct)
View
2020-10-10
Equity Swap
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
39,567$34.50
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
19,755$19.10
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
7,840$34.50
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
52,421$31.480
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
15,398$17.390
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
87,368$28.210
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
7,500$1.710
(Direct)
View
2020-10-13
Disposition
2020-10-14
4:15 pm
N/A
N/A
Aimmune Therapeutics Inc.AIMTIwicki Mark T
Director
11,432$14.60
(Direct)
View
2020-06-30
Option Award
2020-07-02
4:00 pm
N/A
2030-06-30
Merus N.V.MRUSIwicki Mark T
Director
8,631$08,631
(Direct)
View
2020-06-25
Option Award
2020-06-29
9:52 pm
N/A
N/A
Kala Pharmaceuticals Inc.KALAIwicki Mark T
Chief Executive Officer
49,560$049,560
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc.AKROIwicki Mark T
Director
13,000$013,000
(Direct)
View
Goto 0, 1, Next